Literature DB >> 28655726

High density lipoproteins and type 2 inflammatory biomarkers are negatively correlated in atopic asthmatics.

Amisha V Barochia1, Elizabeth M Gordon2, Maryann Kaler2, Rosemarie A Cuento2, Patricia Theard2, Debbie M Figueroa2, Xianglan Yao2, Nargues A Weir2, Maureen L Sampson3, Mario Stylianou4, David F Choy5, Cecile T J Holweg5, Alan T Remaley6, Stewart J Levine2.   

Abstract

Blood eosinophil counts and serum periostin levels are biomarkers of type 2 inflammation. Although serum levels of HDL and apoA-I have been associated with less severe airflow obstruction in asthma, it is not known whether serum lipids or lipoprotein particles are correlated with type 2 inflammation in asthmatics. Here, we assessed whether serum lipids and lipoproteins correlated with blood eosinophil counts or serum periostin levels in 165 atopic asthmatics and 163 nonasthmatic subjects with and without atopy. Serum lipids and lipoproteins were quantified using standard laboratory assays and NMR spectroscopy. Absolute blood eosinophils were quantified by complete blood counts. Periostin levels were measured using the Elecsys® periostin assay. In atopic asthmatics, blood eosinophils negatively correlated with serum HDL cholesterol and total HDL particles measured by NMR spectroscopy (HDLNMR). Serum periostin levels negatively correlated with total HDLNMR In contrast, blood eosinophil counts positively correlated with serum triglyceride levels. This study demonstrates for the first time that HDL particles were negatively correlated, whereas serum triglycerides were positively correlated, with blood eosinophils in atopic asthmatics. This supports the concept that serum levels of HDL and triglycerides may be linked to systemic type 2 inflammation in atopic asthma.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  apolipoproteins; asthma; clinical studies; eosinophils; immunology; inflammation; lung; periostin

Mesh:

Substances:

Year:  2017        PMID: 28655726      PMCID: PMC5538292          DOI: 10.1194/jlr.P077776

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  53 in total

1.  T-helper type 2-driven inflammation defines major subphenotypes of asthma.

Authors:  Prescott G Woodruff; Barmak Modrek; David F Choy; Guiquan Jia; Alexander R Abbas; Almut Ellwanger; Laura L Koth; Joseph R Arron; John V Fahy
Journal:  Am J Respir Crit Care Med       Date:  2009-05-29       Impact factor: 21.405

2.  Revisiting "Good" and "Bad" Cholesterol. The Battle over Flow through Arteries Now Shifts to Flow through Airways.

Authors:  Michael B Fessler
Journal:  Am J Respir Crit Care Med       Date:  2015-05-01       Impact factor: 21.405

3.  High-density lipoprotein particle number: a better measure to quantify high-density lipoprotein?

Authors:  Emil M deGoma; Daniel J Rader
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

4.  Peripheral differential leukocyte counts in humans vary with hyperlipidemia, smoking, and body mass index.

Authors:  Z S Huang; K L Chien; C Y Yang; K S Tsai; C H Wang
Journal:  Lipids       Date:  2001-03       Impact factor: 1.880

5.  Multicenter evaluation of analytical characteristics of the Elecsys® Periostin immunoassay.

Authors:  Stefan Palme; Robert H Christenson; Saeed A Jortani; Richard E Ostlund; Ruediger Kolm; Guido Kopal; Ruediger P Laubender
Journal:  Clin Biochem       Date:  2016-10-08       Impact factor: 3.281

6.  Lipoprotein particles and size, total and high molecular weight adiponectin, and leptin in relation to incident coronary heart disease among severely obese postmenopausal women: The Women's Health Initiative Observational Study.

Authors:  Rachel H Mackey; Kathleen M McTigue; Yuefang F Chang; Emma Barinas-Mitchell; Rhobert W Evans; Lesley F Tinker; Cora E Lewis; JoAnn E Manson; Marcia L Stefanick; Barbara V Howard; Lawrence S Phillips; Simin Liu; Doina Kulick; Lewis H Kuller
Journal:  BBA Clin       Date:  2015-06

7.  Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies.

Authors:  Nicola A Hanania; Michael Noonan; Jonathan Corren; Phillip Korenblat; Yanan Zheng; Saloumeh K Fischer; Melissa Cheu; Wendy S Putnam; Elaine Murray; Heleen Scheerens; Cecile T J Holweg; Romeo Maciuca; Sarah Gray; Ramona Doyle; Dana McClintock; Julie Olsson; John G Matthews; Karl Yen
Journal:  Thorax       Date:  2015-05-22       Impact factor: 9.139

Review 8.  Statins as potential therapeutic drug for asthma?

Authors:  Cheng Yuan; Lin Zhou; Jiyun Cheng; Jingying Zhang; Yue Teng; Mao Huang; Ian M Adcock; Peter J Barnes; Xin Yao
Journal:  Respir Res       Date:  2012-11-24

9.  Plasma Periostin Levels Are Increased in Chinese Subjects with Obesity and Type 2 Diabetes and Are Positively Correlated with Glucose and Lipid Parameters.

Authors:  Yuanyuan Luo; Hua Qu; Hang Wang; Huili Wei; Jing Wu; Yang Duan; Dan Liu; Huacong Deng
Journal:  Mediators Inflamm       Date:  2016-05-22       Impact factor: 4.711

10.  Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.

Authors:  Elisabeth H Bel; Sally E Wenzel; Philip J Thompson; Charlene M Prazma; Oliver N Keene; Steven W Yancey; Hector G Ortega; Ian D Pavord
Journal:  N Engl J Med       Date:  2014-09-08       Impact factor: 91.245

View more
  6 in total

Review 1.  Eosinophilic and Noneosinophilic Asthma.

Authors:  Tara F Carr; Amir A Zeki; Monica Kraft
Journal:  Am J Respir Crit Care Med       Date:  2018-01-01       Impact factor: 21.405

Review 2.  The Gut/Lung Microbiome Axis in Obesity, Asthma, and Bariatric Surgery: A Literature Review.

Authors:  Yeon Ji Kim; Jack T Womble; Claudia K Gunsch; Jennifer L Ingram
Journal:  Obesity (Silver Spring)       Date:  2021-04       Impact factor: 5.002

Review 3.  HDL in Immune-Inflammatory Responses: Implications beyond Cardiovascular Diseases.

Authors:  Fabrizia Bonacina; Angela Pirillo; Alberico L Catapano; Giuseppe D Norata
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600

4.  Transcriptome Analysis of the Effects of Fasting Caecotrophy on Hepatic Lipid Metabolism in New Zealand Rabbits.

Authors:  Yadong Wang; Huifen Xu; Guirong Sun; Mingming Xue; Shuaijie Sun; Tao Huang; Jianshe Zhou; Juan J Loor; Ming Li
Journal:  Animals (Basel)       Date:  2019-09-03       Impact factor: 2.752

5.  Eosinophils Protect Mice From Angiotensin-II Perfusion-Induced Abdominal Aortic Aneurysm.

Authors:  Cong-Lin Liu; Xin Liu; Yuanyuan Zhang; Jing Liu; Chongzhe Yang; Songyuan Luo; Tianxiao Liu; Yunzhe Wang; Jes S Lindholt; Axel Diederichsen; Lars M Rasmussen; Marie Dahl; Galina K Sukhova; Guanyi Lu; Gilbert R Upchurch; Peter Libby; Junli Guo; Jinying Zhang; Guo-Ping Shi
Journal:  Circ Res       Date:  2020-11-06       Impact factor: 17.367

6.  Impacts of lipid-related metabolites, adiposity, and genetic background on blood eosinophil counts: the Nagahama study.

Authors:  Kenta Nishi; Hisako Matsumoto; Noriyuki Tashima; Satoru Terada; Natsuko Nomura; Mariko Kogo; Chie Morimoto; Hironobu Sunadome; Tadao Nagasaki; Tsuyoshi Oguma; Yoshinari Nakatsuka; Kimihiko Murase; Takahisa Kawaguchi; Yasuharu Tabara; Kazuhiro Sonomura; Fumihiko Matsuda; Kazuo Chin; Toyohiro Hirai
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.